Clin2
NCT07363395Likely a fitRecruiting

A study of ASCT-83 in healthy adults

Neuropathic Pain

Part of Brain & nervous system, Injuries & trauma, Pain clinical trials.

This trial tests a new medication called ASCT-83 in healthy adults to see how safe it is and how the body processes it. It may help researchers understand the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
72 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old.
  • You are generally healthy, based on your medical history, a physical exam, and lab tests.
  • Your body mass index (BMI) is between 19 and 35 at the screening visit.
  • If you are able to become pregnant, you agree to use birth control and have pregnancy tests during the study.
  • If you are male, you agree to use birth control and not donate sperm during the study.
  • You do not have any serious health conditions like heart, liver, kidney, immune, or autoimmune diseases.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05968664Recruiting
Test whether new spinal cord stimulation settings improve chronic pain

This trial studies whether changing the “stimulation pattern” of spinal cord stimulation can reduce long-lasting pain and improve daily function. You might be a good candidate if you have chronic trunk or leg pain and have already tried multiple pain treatments without enough relief.

Houston, Texas
NCT07618247Recruiting· Phase 1
Testing a new drug in healthy adults

This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.

Adelaide, South Australia
NCT07335913Recruiting· Phase 1
Testing SBS-147 in healthy adults for safety

This study tests a new drug, SBS-147, in healthy adults to see if it's safe and how the body processes it. It may help find the right dose for future studies in people with certain conditions.

Cypress, California
NCT07823764Not yet recruiting· Phase 1
Testing a new antibody drug in healthy volunteers

This trial tests a new antibody drug called CM583 in healthy people to see if it is safe and how the body handles it. It may help treat conditions related to certain proteins involved in pain and inflammation.

Hangzhou, Zhejiang
NCT07829406Not yet recruiting· Phase 1
Safety study of a new medicine in healthy adults

This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.

Salt Lake City, Utah
NCT07606976Not yet recruiting· Phase 1
Study of a new medicine in healthy adults

This study tests a new investigational medicine in healthy adults to see how safe it is and how the body processes it. It is a first-in-human trial, so it is looking for volunteers who are generally well and have normal immune function.

Shanghai

Hear when a new Neuropathic Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.